Reply to Letter by Hadigal Et Al. Regarding the Cost-Effectiveness of High Dose Quadrivalent Vaccine in Three European Countries
AuthID
P-00Z-5Z0
P-00Z-5Z0
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service